466 related articles for article (PubMed ID: 36203194)
1. Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease.
Li Y; Xia X; Wang Y; Zheng JC
J Neuroinflammation; 2022 Oct; 19(1):248. PubMed ID: 36203194
[TBL] [Abstract][Full Text] [Related]
2. The Role of Microglia with Mitochondrial Dysfunction and Its Therapeutic Prospects in Alzheimer's Disease.
Li Y; Li T; Chen T; Li C; Yu W; Xu Y; Zeng X; Zheng F
J Integr Neurosci; 2024 Apr; 23(5):91. PubMed ID: 38812394
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Regulation of Microglial Immunometabolism in Alzheimer's Disease.
Fairley LH; Wong JH; Barron AM
Front Immunol; 2021; 12():624538. PubMed ID: 33717134
[TBL] [Abstract][Full Text] [Related]
4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer's disease.
Fairley LH; Lai KO; Wong JH; Chong WJ; Vincent AS; D'Agostino G; Wu X; Naik RR; Jayaraman A; Langley SR; Ruedl C; Barron AM
Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2209177120. PubMed ID: 36787364
[TBL] [Abstract][Full Text] [Related]
6. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation of Microglial Regulation in Alzheimer's Disease: Therapeutic Approaches.
Chen H; Zeng Y; Wang D; Li Y; Xing J; Zeng Y; Liu Z; Zhou X; Fan H
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611758
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA and Inflammation in Alzheimer's Disease.
Galizzi G; Di Carlo M
Curr Issues Mol Biol; 2023 Oct; 45(11):8586-8606. PubMed ID: 37998717
[TBL] [Abstract][Full Text] [Related]
9. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
10. Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer's disease.
Yoo SM; Park J; Kim SH; Jung YK
BMB Rep; 2020 Jan; 53(1):35-46. PubMed ID: 31818363
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease.
Gao C; Shen X; Tan Y; Chen S
J Neuroinflammation; 2022 Sep; 19(1):215. PubMed ID: 36058959
[TBL] [Abstract][Full Text] [Related]
12. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases.
Lin MM; Liu N; Qin ZH; Wang Y
Acta Pharmacol Sin; 2022 Oct; 43(10):2439-2447. PubMed ID: 35233090
[TBL] [Abstract][Full Text] [Related]
14. Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer's disease pathology.
Cheng J; Dong Y; Ma J; Pan R; Liao Y; Kong X; Li X; Li S; Chen P; Wang L; Yu Y; Yuan Z
Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34433553
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease.
Onyango I; Khan S; Miller B; Swerdlow R; Trimmer P; Bennett P
J Alzheimers Dis; 2006 Jul; 9(2):183-93. PubMed ID: 16873965
[TBL] [Abstract][Full Text] [Related]
16. Microglial polarization: novel therapeutic mechanism against Alzheimer's disease.
Yao K; Zu HB
Inflammopharmacology; 2020 Feb; 28(1):95-110. PubMed ID: 31264132
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of microglial cathepsins in neurodegenerative disease.
Lowry JR; Klegeris A
Brain Res Bull; 2018 May; 139():144-156. PubMed ID: 29454581
[TBL] [Abstract][Full Text] [Related]
18. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis.
Chakravorty A; Jetto CT; Manjithaya R
Front Aging Neurosci; 2019; 11():311. PubMed ID: 31824296
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?
Mancuso M; Orsucci D; Siciliano G; Murri L
Curr Alzheimer Res; 2008 Oct; 5(5):457-68. PubMed ID: 18855587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
